The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
STRO · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | LH | STRO | NEOG | DAIO |
|---|---|---|---|---|
| Moat Score (0–100) | 39 | 40 (highest) | 40 (highest) | 39 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 38 | 60 (highest) | 60 (highest) | 16 |
| Pricing power | 43 | — | 80 | 91 (highest) |
| Returns on capital | 19 (highest) | 0 | 11 | 11 |
| Balance-sheet safety | 32 | 55 (highest) | 0 | 55 (highest) |
| Capital allocation | 65 (highest) | 44 | 48 | 24 |
| 109% above value if growth stopped today | No price data | No price data | No price data | |
| Market cap | $26.1B | $93.9M | $2.6B | $24.2M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2026 | FY2025 |